Trial Profile
Pharmacokinetics and tolerability of single ascending doses of AP 301 in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2014
Price :
$35
*
At a glance
- Drugs Solnatide (Primary)
- Indications Acute lung injury; Adult respiratory distress syndrome; Pulmonary oedema; Reperfusion injury
- Focus Adverse reactions; Pharmacokinetics
- Sponsors APEPTICO Forschung und Entwicklung
- 11 Apr 2014 New trial record
- 01 Mar 2014 Results published in the Journal of Clinical Pharmacology.